There is hope in sight for people living with sickle cell as United Kingdom’s National Health Service has approved a new and promising treatment for the health condition.

According to a report published by a British online newspaper, The independent, the medication is described as a “revolutionary” life-changing drug treatment for sickle cell disease and the first new treatment for the disease in 20 years.

According to the UK news site, it will be available to only 300 patients initially but will be extended to 450 in the near future after the decision by the National Institute for Health and Care Excellence, which recommended the drug be available on the NHS.

“The new drug, known as crizanlizumab, will be delivered by a transfusion drip and works by binding to a protein in the blood cells to prevent the restriction of blood and oxygen supply.

It could help as many as 5,000 people over the next three years, the NHS has said. It is hoped the drug will reduce the number of times a sickle cell patient needs to go to the Accident & Emergency unit by two-fifths.

“The site also stated that people aged over 16 who suffer from multiple sickle cell crises every year will be eligible for the treatment.

NICE said it could not recommend the drug for routine use yet due to high uncertainty about the long-term effectiveness of the treatment and its associated costs.

The agreement with the NHS will allow patients to access the drug while extra data is collected through clinical trials.”



Comment Here

By PharmaTimes

PharmaTimes offers a unique blend of health stories, interviews, features, covering all aspects of health as it affects every individual and mankind.

Leave a Reply

Your email address will not be published.